lunes, 30 de junio de 2014

Design and Anticipated Outcomes of the e... [Clin Pharmacol Ther. 2014] - PubMed - NCBI

Design and Anticipated Outcomes of the e... [Clin Pharmacol Ther. 2014] - PubMed - NCBI



 2014 Jun 24. doi: 10.1038/clpt.2014.137. [Epub ahead of print]

Design and Anticipated Outcomes of the eMERGE-PGx Project: A Multi-Center Pilot for Pre-Emptive Pharmacogenomics in Electronic Health Record Systems.

Abstract

We describe here the design and initial implementation of the eMERGE-PGx project. eMERGE-PGx, a partnership of the eMERGE and PGRN consortia, has three objectives : 1) Deploy PGRNseq, a next-generation sequencing platform assessing sequence variation in 84 proposed pharmacogenes, in nearly 9,000patients likely to be prescribed drugs of interest in a 1-3 year timeframe across several clinical sites; 2) Integrate well-established clinically-validated pharmacogenetic genotypes into the electronic health record with associated clinical decision support and assess process and clinical outcomes of implementation; and 3) Develop a repository of pharmacogenetic variants of unknown significance linked to a repository of an EHR-based clinical phenotype data for ongoing pharmacogenomics discovery. We describe site-specific project implementation and anticipated products, including genetic variant and phenotype data repositories, novel variant association studies, clinical decision support modules, clinical and process outcomes, approaches to manage incidental findings, and patient and clinician education methods.Clinical Pharmacology & Therapeutics (2014); Accepted article preview online 24 June 2014; doi:10.1038/clpt.2014.138.

PMID:
 
24960519
 
[PubMed - as supplied by publisher]

No hay comentarios:

Publicar un comentario